Form 4: IDEXX Director M. Anne Szostak Sells 3,000 Shares
SEC Form 4
M. Anne Szostak, a director at IDEXX Laboratories Inc, sold 3,000 shares of common stock at a price of $465.945 on February 7, 2025.
Summary
- On February 7, 2025, M. Anne Szostak, a director of IDEXX Laboratories Inc, sold 3,000 shares of common stock.
- The sale price was $465.945 per share.
- Following the transaction, M. Anne Szostak directly owns no shares and indirectly owns 3,061 shares through the Trust of M. Anne Szostak.
- M. Anne Szostak is the settlor and trustee of the Trust, and has the power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale represents a small percentage of the overall shares outstanding for IDEXX.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of transaction: M. Anne Szostak sold 3,000 shares of IDEXX common stock. |
| 02/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.